149 related articles for article (PubMed ID: 33769206)
1. Increased risk for renal cell carcinoma in end stage renal disease - a population-based case-control study.
Åkerlund J; Holmberg E; Lindblad P; Stendahl M; Ljungberg B; Thorstenson A; Lundstam S
Scand J Urol; 2021 Jun; 55(3):209-214. PubMed ID: 33769206
[TBL] [Abstract][Full Text] [Related]
2. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
[TBL] [Abstract][Full Text] [Related]
3. Pathologic characterization of renal epithelial neoplasms arising in nonfunctioning kidneys.
Lin X; Goyal R; Yang XJ
Hum Pathol; 2020 Mar; 97():1-7. PubMed ID: 31857138
[TBL] [Abstract][Full Text] [Related]
4. Renal cell carcinoma in patients with end-stage renal disease is associated with more favourable histological features and prognosis.
Chen K; Huang HH; Aydin H; Tan YH; Lau WK; Cheng CW; Yuen JS
Scand J Urol; 2015 Jun; 49(3):200-4. PubMed ID: 25783025
[TBL] [Abstract][Full Text] [Related]
5. Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population.
Breda A; Lucarelli G; Rodriguez-Faba O; Guirado L; Facundo C; Bettocchi C; Gesualdo L; Castellano G; Grandaliano G; Battaglia M; Palou J; Ditonno P; Villavicencio H
World J Urol; 2015 Jan; 33(1):1-7. PubMed ID: 24504760
[TBL] [Abstract][Full Text] [Related]
6. Outcome of advanced renal cell carcinoma arising in end-stage renal disease: comparison with sporadic renal cell carcinoma.
Ishihara H; Fukuda H; Tachibana H; Yoshida K; Kobayashi H; Takagi T; Iizuka J; Ishida H; Nagashima Y; Kondo T; Tanabe K
Clin Exp Nephrol; 2021 Jun; 25(6):674-682. PubMed ID: 33641007
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.
Tickoo SK; dePeralta-Venturina MN; Harik LR; Worcester HD; Salama ME; Young AN; Moch H; Amin MB
Am J Surg Pathol; 2006 Feb; 30(2):141-53. PubMed ID: 16434887
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of end-stage renal disease in patients with renal cell carcinoma: a 12-year nationwide follow-up study.
Hung PH; Tsai HB; Hung KY; Muo CH; Chung MC; Chang CH; Chung CJ
Medicine (Baltimore); 2014 Aug; 93(8):e52. PubMed ID: 25121356
[TBL] [Abstract][Full Text] [Related]
9. Renal Cell Carcinoma in End-Stage Renal Disease: A Retrospective Study in Patients from Hungary.
Semjén D; Dénes B; Somorácz Á; Fintha A; Forika G; Jenei A; Dobi D; Micsik T; Eizler KV; Giba N; Sánta F; Sejben A; Iványi B; Kuthi L
Pathobiology; 2023; 90(5):322-332. PubMed ID: 36696889
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma in patients with end-stage renal disease has favorable overall prognosis.
Shrewsberry AB; Osunkoya AO; Jiang K; Westby R; Canter D; Pattaras J; Turgeon N; Master VA; Ogan K
Clin Transplant; 2014 Feb; 28(2):211-6. PubMed ID: 24494735
[TBL] [Abstract][Full Text] [Related]
11. Renal cell carcinoma as a cause of end-stage renal disease in the United States: patient characteristics and survival.
Stiles KP; Moffatt MJ; Agodoa LY; Swanson SJ; Abbott KC
Kidney Int; 2003 Jul; 64(1):247-53. PubMed ID: 12787416
[TBL] [Abstract][Full Text] [Related]
12. Acquired cystic disease-associated renal cell carcinoma is the most common subtype in long-term dialyzed patients: Central pathology results according to the 2016 WHO classification in a multi-institutional study.
Kondo T; Sasa N; Yamada H; Takagi T; Iizuka J; Kobayashi H; Yoshida K; Fukuda H; Ishihara H; Tanabe K; Tsuzuki T
Pathol Int; 2018 Oct; 68(10):543-549. PubMed ID: 30187581
[TBL] [Abstract][Full Text] [Related]
13. Comparable survival outcome between acquired cystic disease associated renal cell carcinoma and clear cell carcinoma in patients with end-stage renal disease: a multi-institutional central pathology study.
Kondo T; Sassa N; Yamada H; Takagi T; Iizuka J; Kobayashi H; Yoshida K; Fukuda H; Ishihara H; Tanabe K; Tsuzuki T
Pathology; 2021 Oct; 53(6):720-727. PubMed ID: 33947521
[TBL] [Abstract][Full Text] [Related]
14. Renal cell carcinoma outcomes in end-stage renal disease: A 40-year study from two Japanese institutions.
Ishihara H; Ikeda T; Fukuda H; Yoshida K; Kobayashi H; Iizuka J; Nagashima Y; Kondo T; Takagi T
Int J Urol; 2024 Jan; 31(1):73-81. PubMed ID: 37798866
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis.
Denton MD; Magee CC; Ovuworie C; Mauiyyedi S; Pascual M; Colvin RB; Cosimi AB; Tolkoff-Rubin N
Kidney Int; 2002 Jun; 61(6):2201-9. PubMed ID: 12028461
[TBL] [Abstract][Full Text] [Related]
16. Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.
Neuzillet Y; Tillou X; Mathieu R; Long JA; Gigante M; Paparel P; Poissonnier L; Baumert H; Escudier B; Lang H; Rioux-Leclercq N; Bigot P; Bernhard JC; Albiges L; Bastien L; Petit J; Saint F; Bruyere F; Boutin JM; Brichart N; Karam G; Branchereau J; Ferriere JM; Wallerand H; Barbet S; Elkentaoui H; Hubert J; Feuillu B; Theveniaud PE; Villers A; Zini L; Descazeaux A; Roupret M; Barrou B; Fehri K; Lebret T; Tostain J; Terrier JE; Terrier N; Martin L; Dugardin F; Galliot I; Staerman F; Azemar MD; Irani J; Tisserand B; Timsit MO; Sallusto F; Rischmann P; Guy L; Valeri A; Deruelle C; Azzouzi AR; Chautard D; Mejean A; Salomon L; Rigaud J; Pfister C; Soulié M; Kleinclauss F; Badet L; Patard JJ; ;
Eur Urol; 2011 Aug; 60(2):366-73. PubMed ID: 21377780
[TBL] [Abstract][Full Text] [Related]
17. The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans.
Hofmann JN; Schwartz K; Chow WH; Ruterbusch JJ; Shuch BM; Karami S; Rothman N; Wacholder S; Graubard BI; Colt JS; Purdue MP
Cancer Causes Control; 2013 Jan; 24(1):167-74. PubMed ID: 23179659
[TBL] [Abstract][Full Text] [Related]
18. Renal cell carcinoma and end stage renal disease.
Farivar-Mohseni H; Perlmutter AE; Wilson S; Shingleton WB; Bigler SA; Fowler JE
J Urol; 2006 Jun; 175(6):2018-20; discussion 2021. PubMed ID: 16697788
[TBL] [Abstract][Full Text] [Related]
19. [The clinicopathological characteristics in renal cell carcinoma with end-stage renal disease].
Maru N; Iwamura M; Ishii J; Minei S; Saito T; Yoshida K; Baba S
Nihon Hinyokika Gakkai Zasshi; 2003 Mar; 94(3):434-8. PubMed ID: 12710078
[TBL] [Abstract][Full Text] [Related]
20. Risk of end-stage renal disease after cancer nephrectomy in Taiwan: a nationwide population-based study.
Lin WY; Liang FW; Lu TH
PLoS One; 2015; 10(5):e0126965. PubMed ID: 25993556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
